6.600
−1,49%
2026-10-19
Fundamental Analysis
48 / 100—Rubric: Manufacturing
Not rated — insufficient or unsupported data
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +32.9% | +738.2% | 2 / 3 | — | — | — | +0.7% | 0.00 | 78.03 | 0,0 | — | — | — | 78.03 | 117.17 | −33,4% |
| Pts | 8 | 12 | 8 | 0 | 0 | 0 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 6.600 (close price on 2026-10-19)EPS (TTM): 84,6
Financial charts
1.Revenue & growth
VND bn0,00Q2/26
1.Revenue & growth
VND bn0,00Q2/26
2.Profit & growth
VND bn1,80Q2/26
3.Profit mix (Penman)
VND bn3,09Q2/26
4.Margins & cost structure
%
5.Returns & cash cycle
% · days-0.5%Q2/26
6.Earnings quality & cash
VND bn-2,67Q2/26
7.Asset structure
VND bn403Q2/26
8.Funding & debt health
VND bn · times403Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %76,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %56Q2/26
Adjusted EPS growth, latest quarter
36.6%
Average adjusted EPS growth, 3 quarters
15,7× higher
averaged over 2 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26